2009-10-08 - Axcentua Pharmaceuticals ABAxcentua Pharmaceuticals closed its series-A financing round led by the entrepreneur William Gunnarsson, the former CEO and co-founder of Orphan Europe. The financing will enable Axcentua to advance its multi-targeted lead molecule AXP107-11 into clinical...